 Your new post is loading...
 Your new post is loading...
|
Scooped by
Gilbert C FAURE
July 31, 2012 4:16 AM
|
World's first dengue vaccine beats three virus strainsFox NewsSanofi's vaccine generated an antibody response for all four dengue virus types, but evidence of protection was only demonstrated against three of the four strains circulating in Thailand.
|
Scooped by
Gilbert C FAURE
July 30, 2012 2:34 PM
|
The Anti-IL17A Monoclonal Antibody Secukinumab in ...
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:28 PM
|
Published Findings In Human Gene Therapy Methods Journal Demonstrate ...MarketWatch (press release)"The clinical success of DNA-based therapies can be enhanced by employing optimized gene delivery methods," stated Dr.
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:24 PM
|
New Published Paper Shows Efficacy of Lpath's Anti-LPA Antibody, Lpathomab ...MarketWatch (press release)Lpath utilized ImmuneY2 to discover an antibody against another bioactive lipid, sphingosine-1-phosphate (S1P).
|
Scooped by
Gilbert C FAURE
July 29, 2012 4:01 PM
|
89.3 KPCCCIRM awards $151 million in stem cell grants to 8 projects statewide89.3 KPCCThis week, California's public stem-cell agency awarded more than $150 million to advance research into eight diseases now under study by researchers at several...
|
Scooped by
Gilbert C FAURE
July 29, 2012 3:35 AM
|
Stem cell injections in dogs will become routine in the next two years and will probably cost less than $1000.
|
Scooped by
Gilbert C FAURE
July 29, 2012 3:14 AM
|
Cancer Biotherapy and Radiopharmaceuticals (http://www.liebertpub.com/cbr), published 10 times a year in print and online, is under the editorial leadership of Editors Donald J. Buchsbaum, PhD and Robert K.
|
Scooped by
Gilbert C FAURE
July 28, 2012 3:07 PM
|
ROR1, receptor tyrosine kinase like orphan receptor one, is a molecule expressed at high levels during embryogenesis that plays a major role in the development of the skeleton, lungs and nervous sy...
|
Scooped by
Gilbert C FAURE
July 28, 2012 3:02 PM
|
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:58 PM
|
Clinical Immunology Society Announces Updated WEBbook of Biologic ...DigitalJournal.com (press release)The Clinical Immunology Society (CIS) maintains the WEBbook of Biologic Therapies as a service to the Society members and the medical community...
|
Scooped by
Gilbert C FAURE
July 28, 2012 5:09 AM
|
OMT Announces New Antibody Discovery ProgramMarketWatch (press release)Open Monoclonal Technology, Inc. ("OMT") is a private biotechnology company that is the first to develop a fully human monoclonal antibody platform based on transgenic rats.
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:46 AM
|
SAN DIEGO (CNS) - Researchers from San Diego State University's Heart Institute rejuvenated damaged cardiac tissue removed from older heart-failure patients, using modified stem cells.
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:43 AM
|
“@Artritis_Celso:Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive,RA pat.
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 4:12 AM
|
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:29 PM
|
BBC NewsUniQure's Glybera Wins EU Backing as First Gene TherapyBusinessweekEurope is on the cusp of approving the first gene therapy to be sold on the market in a western nation, a product from UniQure BV designed to treat a rare disease that...
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:27 PM
|
Research from University of Oxford Has Provided New Information about ...Equities.comAccording to news reporting from Oxford, United Kingdom, by NewsRx journalists, researchers stated "Ipilimumab (Yervoy; Medarex and Bristol-Myers Squibb) is a...
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:23 PM
|
iBio, Inc.and GE Healthcare form new global allianceMarketWatch (press release)We look forward to working together on the development of a flexible and cost-effective plant-based manufacturing platform that has the potential to assist in the global...
|
Scooped by
Gilbert C FAURE
July 29, 2012 2:52 PM
|
Researchers Study Vaccine Created from Patient Blood Cells as Potential ...MarketWatch (press release)Researchers at Northwestern Brain Tumor Institute (NBTI) are seeking to understand if a vaccine made from a patient's own blood cells may slow the...
|
Scooped by
Gilbert C FAURE
July 29, 2012 3:19 AM
|
Specificity: CD253 Product Page: TNFSF10 antibody (OASA07564) Antibody Pair Available: OASA07564 Capture OASA07567 Detection Experiment Type: Mice and treatments, Antibodies, flow cytometry, and cell sorting ...
|
Scooped by
Gilbert C FAURE
July 29, 2012 3:14 AM
|
We look forward to working together on the development of a flexible and cost-effective plant-based manufacturing platform that has the potential to assist in the global effort to increase access to biotherapeutics and help reduce the ...
|
Scooped by
Gilbert C FAURE
July 28, 2012 3:06 PM
|
More importantly, in vitro experiments, the monoclonal antibody in very low concentrations can effectively prevent the virus from invading cells, suggesting that they have developed into a humanized monoclonal antibody drug ...
|
Scooped by
Gilbert C FAURE
July 28, 2012 3:01 PM
|
Uploaded and Shares in Youtube by: AssoEFP Mechanism of action of dual-immunosuppression in solid organ transplantation. EFP website: www.efp-online.org.
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:52 PM
|
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
Scooped by
Gilbert C FAURE
July 28, 2012 4:21 AM
|
Posted: Jul 26th, 2012. Nanoscale scaffolds spur stem cells to cartilage repair. (Nanowerk News) A spun 3-D scaffold of nanofibers did a better job of producing larger quantities of and a more durable type of the cartilage protein than flat, 2-D ...
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:43 AM
|
Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. By - Prof Martin J Elliott MD, Paolo De Coppi MD, Simone Speggiorin MD, Derek Roebuck MB, Colin R Butle...
|